Pyxis Oncology, Inc.
PYXS
$1.84
-$1.53-45.40%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -97.09M | -96.29M | -95.23M | -77.33M | -57.36M |
| Total Depreciation and Amortization | 2.16M | 2.37M | 2.42M | 2.98M | 3.12M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 30.13M | 28.89M | 27.97M | 28.50M | 8.07M |
| Change in Net Operating Assets | -7.57M | -8.72M | 5.35M | -11.82M | -7.47M |
| Cash from Operations | -72.37M | -73.75M | -59.50M | -57.67M | -53.64M |
| Capital Expenditure | -9.00K | 0.00 | 0.00 | -237.00K | -237.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 1.00K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 69.26M | 57.77M | 42.47M | 8.39M | -8.04M |
| Cash from Investing | 69.25M | 57.77M | 42.47M | 8.16M | -8.27M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.00K | 1.66M | 1.81M | 59.52M | 59.54M |
| Repurchase of Common Stock | -7.73M | -7.72M | -7.70M | -7.89M | -292.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 7.70M | 7.70M | 7.70M | 7.70M | -- |
| Cash from Financing | -25.00K | 1.64M | 1.82M | 59.33M | 59.25M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.14M | -14.34M | -15.21M | 9.81M | -2.66M |